Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Helmig

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancers|September 13, 2025
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing SarcomaJessica Gartrell, Fariba Navid, Xiaomeng Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322AWayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk NeuroblastomaWayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Thyroid : Official Journal of the American Thyroid Association|February 14, 2025
Composition and Priorities of Multidisciplinary Pediatric Thyroid Programs: A Consensus StatementRonik Kothari, Julia R Donner, Karthik Balakrishnan, et al.
Cancer|October 13, 2021
Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequencesWassim Chemaitilly, Zhenghong Li, Tara M Brinkman, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancers|September 13, 2025
ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing SarcomaJessica Gartrell, Fariba Navid, Xiaomeng Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322AWayne L Furman, Beth McCarville, Barry L Shulkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk NeuroblastomaWayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Thyroid : Official Journal of the American Thyroid Association|February 14, 2025
Composition and Priorities of Multidisciplinary Pediatric Thyroid Programs: A Consensus StatementRonik Kothari, Julia R Donner, Karthik Balakrishnan, et al.
Cancer|October 13, 2021
Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequencesWassim Chemaitilly, Zhenghong Li, Tara M Brinkman, et al.
Pageof 2